Antibodies against factor VIII in patients with solid tumors: successful treatment of cancer may suppress inhibitor formation.
Between 1995 and 1998, we treated 5 patients with anti-factor VIII antibodies and spontaneous bleeding. All patients had underlying malignant conditions. Initial control of the bleeding episodes and reduction in inhibitor titer was achieved in all patients. Disappearance of factor VIII inhibitor occurred in 3 patients after either resection of the tumor or chemotherapy. Immunosuppression therapy failed to eradicate the antibody in 2 patients with metastatic disease. Antibodies against factor VIII appearing in certain patients may be directly associated with the underlying malignancy, rather than a coincidental finding. Attempts to reduce the titer or eradicate the inhibitor may fail if recognition of the underlying condition is not sought, or an appropriate treatment of cancer is not offered.
Department of Medicine, Division of Hematology/Oncology, University of Tennessee, Memphis, Tenn. 38163, USA.
S
S
Sallah
P
P
Singh
L R
LR
Hanrahan
D000368:Aged; D000906:Antibodies / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003864:Depression, Chemical; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D012189:Retrospective Studies; D016896:Treatment Outcome
D000906:Antibodies; D005169:Factor VIII